Congress 114 - HR 3680 - Co-Prescribing to Reduce Overdoses Act of 2016

Sponsor

Cosponsors

Topics

Drug therapy Drug trafficking and controlled substances Drug, alcohol, tobacco use Health Health programs administration and funding Prescription drugs State and local government operations

Full Text

View Full Bill Text

Votes

Summary

Co-Prescribing to Reduce Overdoses Act of 2016

(Sec. 2) This bill permits the Department of Health and Human Services (HHS) to establish a grant program to support prescribing opioid overdose reversal drugs, such as naloxone, for patients at an elevated risk of overdose, including patients prescribed an opioid. (Opioids are drugs with effects similar to opium, such as heroin and certain pain medications.)

Grant recipients may use the funds to purchase opioid overdose reversal drugs, establish a program for prescribing such drugs, train health care providers and pharmacists, track patients and outcomes, offset patient cost sharing, conduct community outreach, and connect patients to treatment.

(Sec. 3) HHS may provide information to prescribers in federally qualified health centers and Indian Health Service facilities on best practices for prescribing opioid overdose reversal drugs for patients at an elevated risk of overdose.

(Sec. 4) This bill amends the Public Health Service Act to reduce, as an offset, the authorization of appropriations for Centers for Disease Control and Prevention facilities for FY2018.

Actions

May 12, 2016

Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
May 11, 2016

Motion to reconsider laid on the table Agreed to without objection.
May 11, 2016

On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H2256-2257)
May 11, 2016

Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H2256-2257)
May 11, 2016

DEBATE - The House proceeded with forty minutes of debate on H.R. 3680.
May 11, 2016

Considered under suspension of the rules. (consideration: CR H2256-2259)
May 11, 2016

Mr. Guthrie moved to suspend the rules and pass the bill, as amended.
May 10, 2016

Placed on the Union Calendar, Calendar No. 427.
May 10, 2016

Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 114-553.
Apr 28, 2016

Ordered to be Reported (Amended) by Voice Vote.
Apr 28, 2016

Committee Consideration and Mark-up Session Held.
Apr 27, 2016

Committee Consideration and Mark-up Session Held.
Apr 26, 2016

Committee Consideration and Mark-up Session Held.
Apr 25, 2016

Committee Consideration and Mark-up Session Held.
Apr 20, 2016

Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .
Apr 20, 2016

Subcommittee Consideration and Mark-up Session Held.
Oct 2, 2015

Referred to the Subcommittee on Health.
Oct 1, 2015

Referred to the House Committee on Energy and Commerce.
Oct 1, 2015

Introduced in House

Amendments

Related Bills